Trials in Progress Poster Session: Testicular Cancer

1 Presentation only
Shalini Subramaniam, Guy C. Toner, Martin R. Stockler, et al.
The authors conclude: The first planned interim analysis for safety (n=76) identified no safety concerns. The stage I analysis is anticipated mid-2021. This international randomised trial of chemotherapy for intermediate and poor-risk metastatic GCT is the first to include adults and children of both sexes. NCT02582697 Clinical trial information: NCT02582697